ResMed to Report Third Quarter Fiscal 2021 Earnings on April 29, 2021
ResMed plans to release its third-quarter fiscal year 2021 financial results on April 29, 2021, post-market closure. The earnings call will be hosted by management at 1:30 p.m. PDT (4:30 p.m. EDT) with an international audience included. A webcast link for the earnings results is provided for stakeholders. A replay of the webcast will be available shortly after, with a phone replay accessible until May 13, 2021. ResMed is committed to providing innovative healthcare solutions for chronic diseases worldwide, with operations in over 140 countries.
- Plans to release third-quarter results on April 29, 2021.
- Increased transparency with the earnings webcast.
- None.
SAN DIEGO, April 08, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2021 on Thursday, April 29, 2021, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss these results. Other forward-looking and material information may also be discussed during this webcast.
Earnings webcast details:
| • Location: | http://investor.resmed.com | |
| • Date: | Thursday, April 29, 2021 | |
| • Time: | 1:30 p.m. PDT / 4:30 p.m. EDT | |
| • International: | London, Thursday, April 29, 9:30 p.m. BST | |
| Sydney, Friday, April 30, 6:30 a.m. AEST |
Please note that ResMed does not use outside phone lines to access the earnings call.
A replay of the earnings webcast will be accessible on ResMed’s website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately two hours after the webcast and will be accessible from April 29 until May 13 at:
- U.S.: +1 800.585.8367
- International: +1 416.621.4642
- Conference ID: 7757454
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
| For investors Amy Wakeham +1 858.836.5000 investorrelations@resmed.com | For media Jayme Rubenstein +1 858.836.6798 news@resmed.com |
FAQ
When will ResMed release its financial results for the third quarter of FY 2021?
What time is the ResMed earnings webcast scheduled?
How can I access the ResMed earnings call replay?
What is ResMed's stock symbol?
